We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
ASML
ASML
$665B
| $633K | ﹤0.01% |
6,263
+54
| +0.9% | +$5.68K |
|
2152
HealthStream
HSTM
$844M
| $632K | ﹤0.01% |
25,096
+3,325
| +15% | +$90.5K |
|
|
FMI
2153
DELISTED
Foundation Medicine, Inc.
FMI
| $630K | ﹤0.01% |
13,103
+2,405
| +22% | +$109K |
|
|
FNBC
2154
DELISTED
First NBC Bank Holding Company
FNBC
| $629K | ﹤0.01% |
19,083
+1,100
| +6% | +$36.2K |
|
|
LDL
2155
DELISTED
Lydall, Inc.
LDL
| $628K | ﹤0.01% |
19,786
+2,150
| +12% | +$65.6K |
|
2156
Kosmos Energy
KOS
$1.52B
| $627K | ﹤0.01% |
79,209
+3,190
| +4% | +$26.8K |
|
2157
Hawkins
HWKN
$2.7B
| $625K | ﹤0.01% |
32,884
+2,700
| +9% | +$52.7K |
|
|
MKTO
2158
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $625K | ﹤0.01% |
24,412
+4,265
| +21% | +$127K |
|
2159
Primoris Services
PRIM
$4.48B
| $624K | ﹤0.01% |
36,323
+5,375
| +17% | +$105K |
|
|
TESO
2160
DELISTED
Tesco Corp
TESO
| $624K | ﹤0.01% |
54,909
+2,700
| +5% | +$29.6K |
|
|
WPP
2161
DELISTED
WAUSAU PAPER CORP.
WPP
| $624K | ﹤0.01% |
65,442
+9,400
| +17% | +$91.3K |
|
2162
Coeur Mining
CDE
$17.7B
| $623K | ﹤0.01% |
132,282
-700
| -0.5% | -$4.07K |
|
2163
Rockwell Medical
RMTI
$29.2M
| $623K | ﹤0.01% |
518
+72
| +16% | +$84.3K |
|
2164
American Public Education
APEI
$958M
| $622K | ﹤0.01% |
20,760
+2,550
| +14% | +$85K |
|
2165
Stride
LRN
$3.37B
| $619K | ﹤0.01% |
39,350
+2,500
| +7% | +$37.1K |
|
2166
Great Southern Bancorp
GSBC
$882M
| $618K | ﹤0.01% |
15,681
+400
| +3% | +$15K |
|
|
BKYF
2167
DELISTED
BK KY FINL CORP
BKYF
| $617K | ﹤0.01% |
12,581
+200
| +2% | +$9.44K |
|
|
XOXO
2168
DELISTED
Xo Group Inc
XOXO
| $616K | ﹤0.01% |
34,854
+5,200
| +18% | +$87.9K |
|
2169
CorVel
CRVL
$3.23B
| $615K | ﹤0.01% |
53,601
+4,500
| +9% | +$52.5K |
|
2170
LivePerson
LPSN
$28.7M
| $615K | ﹤0.01% |
4,006
+583
| +17% | +$98.5K |
|
2171
Daktronics
DAKT
$1.03B
| $614K | ﹤0.01% |
56,805
+5,700
| +11% | +$66.1K |
|
|
SPPI
2172
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $614K | ﹤0.01% |
101,125
+6,550
| +7% | +$43.6K |
|
2173
Ericsson
ERIC
$33.3B
| $612K | ﹤0.01% |
48,796
+2,636
| +6% | +$33K |
|
|
ISEE
2174
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $611K | ﹤0.01% |
13,139
+2,245
| +21% | +$117K |
|
|
INSY
2175
DELISTED
Insys Therapeutics, Inc.
INSY
| $606K | ﹤0.01% |
20,842
+2,650
| +15% | +$70.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.